![3-(2,4-difluorophenyl)-10-methyl-6-propyl-2,4-dihydropyrano[3,2-g][1,3]benzoxazin-8-one structure](/static/products/877/877803-76-4.png)
3-(2,4-difluorophenyl)-10-methyl-6-propyl-2,4-dihydropyrano[3,2-g][1,3]benzoxazin-8-one
TL;DR: 3-(2,4-difluorophenyl)-10-methyl-6-propyl-2,4-dihydropyrano[3,2-g][1,3]benzoxazin-8-one (CAS 877803-76-4) is a chemical compound with molecular formula C21H19F2NO3 and molecular weight 371.13 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
3-(2,4-difluorophenyl)-10-methyl-6-propyl-2,4-dihydropyrano[3,2-g][1,3]benzoxazin-8-one
Also Known As: 3-(2,4-difluorophenyl)-10-methyl-6-propyl-2,4-dihydropyrano[3,2-g][1,3]benzoxazin-8-one, 3-(2,4-difluorophenyl)-10-methyl-6-propyl-3,4-dihydro-2H,8H-chromeno[6,7-e][1,3]oxazin-8-one, 3-(2,4-difluorophenyl)-10-methyl-6-propyl-3,4-dihydrochromeno[6,7-e][1,3]oxazin-8(2H)-one
| Molecular Formula | C21H19F2NO3 |
|---|---|
| Molecular Weight | 371.13 g/mol |
| LogP | 4.68862 |
| Topological Polar Surface Area | 42.68 Ų |
| Hydrogen Bond Donors | 0 |
| Hydrogen Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Exact Mass | 371.1333 |
| Heavy Atoms | 27 |
| Complexity | 1090.9574 |
Chemical Identifiers
| CAS Number | 877803-76-4 |
|---|---|
| SMILES | CCCC1=CC(=O)OC2=C1C=C3CN(COC3=C2C)C4=C(C=C(C=C4)F)F |
Product Overview
3-(2,4-difluorophenyl)-10-methyl-6-propyl-2,4-dihydropyrano[3,2-g][1,3]benzoxazin-8-one (CAS 877803-76-4), with molecular formula C21H19F2NO3 and molecular weight 371.13 g/mol. IUPAC: 3-(2,4-difluorophenyl)-10-methyl-6-propyl-2,4-dihydropyrano[3,2-g][1,3]benzoxazin-8-one.
Chemical Property Profile of 3-(2,4-difluorophenyl)-10-methyl-6-propyl-2,4-dihydropyrano[3,2-g][1,3]benzoxazin-8-one
Property Insights of 3-(2,4-difluorophenyl)-10-methyl-6-propyl-2,4-dihydropyrano[3,2-g][1,3]benzoxazin-8-one
The XLogP value of 4.68862 indicates that 3-(2,4-difluorophenyl)-10-methyl-6-propyl-2,4-dihydropyrano[3,2-g][1,3]benzoxazin-8-one is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. With a topological polar surface area (TPSA) of 42.68 Ų, 3-(2,4-difluorophenyl)-10-methyl-6-propyl-2,4-dihydropyrano[3,2-g][1,3]benzoxazin-8-one exhibits relatively low polarity, potentially indicating favorable cell membrane permeability. Following Lipinski's Rule of Five, 3-(2,4-difluorophenyl)-10-methyl-6-propyl-2,4-dihydropyrano[3,2-g][1,3]benzoxazin-8-one has 0 hydrogen bond donor(s) and 4 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 3-(2,4-difluorophenyl)-10-methyl-6-propyl-2,4-dihydropyrano[3,2-g][1,3]benzoxazin-8-one?
The CAS number of 3-(2,4-difluorophenyl)-10-methyl-6-propyl-2,4-dihydropyrano[3,2-g][1,3]benzoxazin-8-one is 877803-76-4.
What is the molecular formula of 3-(2,4-difluorophenyl)-10-methyl-6-propyl-2,4-dihydropyrano[3,2-g][1,3]benzoxazin-8-one?
The molecular formula of 3-(2,4-difluorophenyl)-10-methyl-6-propyl-2,4-dihydropyrano[3,2-g][1,3]benzoxazin-8-one is C21H19F2NO3.
What is the molecular weight of 3-(2,4-difluorophenyl)-10-methyl-6-propyl-2,4-dihydropyrano[3,2-g][1,3]benzoxazin-8-one?
The molecular weight of 3-(2,4-difluorophenyl)-10-methyl-6-propyl-2,4-dihydropyrano[3,2-g][1,3]benzoxazin-8-one is 371.13 g/mol.
Where can I buy 3-(2,4-difluorophenyl)-10-methyl-6-propyl-2,4-dihydropyrano[3,2-g][1,3]benzoxazin-8-one?
You can request a quote for 3-(2,4-difluorophenyl)-10-methyl-6-propyl-2,4-dihydropyrano[3,2-g][1,3]benzoxazin-8-one directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 3-(2,4-difluorophenyl)-10-methyl-6-propyl-2,4-dihydropyrano[3,2-g][1,3]benzoxazin-8-one?
Yes, KEHONG BIO provides custom synthesis services for 3-(2,4-difluorophenyl)-10-methyl-6-propyl-2,4-dihydropyrano[3,2-g][1,3]benzoxazin-8-one and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.